期刊文献+

胰岛素样生长因子1对PC12细胞胱硫醚-β-合成酶和硫化氢的影响及机制

Effects of insulin-like growth factor-1 on cystationine-β-synthase and hydrogen sulfide in PC12 cells
下载PDF
导出
摘要 目的观察胰岛素样生长因子1(IGF-1)对大鼠嗜铬细胞瘤细胞(PC12)胱硫醚-β-合成酶(CBS)及硫化氢(H2S)表达的影响以及可能的细胞信号通路机制。方法用不同剂量IGF-1(20、40、80ng/ml)作用体外培养的PC12细胞24h,荧光定量PCR检测CBS基因表达,蛋白质印迹分析检测CBS、细胞外信号调节激酶/丝裂原活化蛋白激酶(ERK/MAPK)相关蛋白表达,敏感硫电极法检测H2S气体含量。之后选取最佳剂量的IGF-1(80ng/ml)作用于30min前已加入ERK/MAPK抑制剂PD98059的PC12细胞再次检测CBS、ERK/MAPK相关蛋白及H2S气体表达水平。结果 IGF-1增加CBS的表达和H2S的含量,上调pERK1/2的表达;而PD98059能够抑制IGF-1的上述作用。结论 IGF-1及其调控的ERK/MAPK信号通路参与调节CBS及H2S的表达。 Objective To investigate the effect of insulin-like growth factor-1 (IGF-1) on expression of cystationine-β-synthase(CBS)and hydrogen sulfide(H2S) in rat adrenal pheochromocytoma cell line (PC12) and the possible signaling pathway.Methods After PC12 cells were treated with 20,40,or 80 ng/ml IGF-1 for 24 h,fluorecence quantitative PCR was used to examined the expression of CBS gene,Western blotting analysis was used to detect the expression of CBS,ERK/MAPK protein expression,and sensitive sulphur electrode was used to analyze the levels of H2S gas.For inhibition studies,25 or 50 mol/L PD98059,a specific ERK/MAPK inhibitor,was used 30 min prior to 80 ng/ml IGF-1 treatment; and the above parameters were examined again using the same method.Results IGF-1 increased the expression of CBS,pERK1/2,and the levels of H2S;and PD98059 could inhibit the above effect of IGF-1.Conclusion IGF-1 and its ERK/MAPK signaling pathway regulate the expression of CBS and levels of H2S.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第12期1296-1299,共4页 Academic Journal of Second Military Medical University
基金 重庆市医学科研计划项目(2010-1-17)~~
关键词 胰岛素样生长因子1 丝裂原活化蛋白激酶类 胱硫醚-Β-合成酶 硫化氢 insulin-like growth factor-1; mitogen-activated protein kinases; cystationine-β-synthase; hydrogen sulfide;
  • 相关文献

参考文献5

二级参考文献72

  • 1耿彬,常林,杜军保,唐朝枢.防治高同型半胱氨酸血症的新策略[J].北京大学学报(医学版),2005,37(2):215-219. 被引量:38
  • 2耿彬,杜军保,唐朝枢北京大学第一医院心血管研究所.敏感硫电极法在测定心血管组织细胞及血浆胱硫醚-γ-裂解酶/硫化氢的应用[J].北京大学学报(医学版),2005,37(5):545-548. 被引量:85
  • 3刘祥琴,晏勇.神经系统中内源性硫化氢的研究进展[J].生理科学进展,2007,38(2):177-180. 被引量:8
  • 4Takashi K, Kazunori I, Hitoshi T. Are cerebrovascular factors involved in Alzbeimer's disease. Neurobiol Aging, 2001, 21: 1215-1224.
  • 5Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging, 2000, 21:321-330.
  • 6McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzhelmer's Disease. Neurology, 1984, 34:939-944.
  • 7Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43 : 250-260.
  • 8Eto K, Asada T, Arima K, et al. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun, 2002, 293 : 1485-1488.
  • 9Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite “scavenger”? Neuroehem, 2004, 90:765-768.
  • 10Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal, 2003, 5:493-501.

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部